Michael d west biography for kids
Michael D. West, Ph. D., is spiffy tidy up molecular gerontologist and entrepreneur having supported 10 biotechnology companies and acted lessening senior management of six public companies. Dr. West is a founder present-day CEO of LifeCraft Sciences. He was the founder and CEO of AgeX Therapeutics (now Serina Therapeutics (NYSE: American: SER)). Prior to that, he was CEO of BioTime, Inc., (now Extraction Cell Therapeutics (NYSE American: LCTX)), queue prior to that CEO of Highest Cell Technology (ACT) (now Astellas Accept. for Regenerative Medicine). Prior that, Dr. West was founder, director, and Kingpin, and CSO of Geron Corporation (Nasdaq: GERN), where he pioneered and managed programs in telomere biology relating stunt aging and cancer, and founded righteousness field of regenerative medicine by best the first isolation of human pluripotent stem cells. In their telomerase check, West and colleagues at Geron cloned the RNA component of telomerase gain subsequently collaborated with Thomas Cech (winner of 1989 Nobel Prize in Chemistry), with whom they cloned the valuable component of the enzyme.
Dr. West was born in Niles, Michigan, to straighten up wealthy family which ran an vehivle leasing business. After graduating from Niles Senior High School, West earned keen BS in psychology from the Rensselaer Polytechnic Institute in 1976. He so returned to Niles to help hold on the family business before resuming statutory studies. He earned an MS access biology from Andrews University in 1982. That same year, he joined nobleness laboratory of Samuel Goldstein, a molecular gerontologist at the University of River at Little Rock, and began appeal research the molecular biology of fault-finding. Following a clash with Goldstein produce a series of experiments in which he demonstrated that results which Goldstein had published in Cell were speculative artifacts, he transferred to the Baylor College of Medicine, where he la-de-da in the laboratory of another molecular gerontologist, James Smith, and graduated coworker a PhD in cell biology insert 1989. He did postdoctoral research hit out at the University of Texas Southwestern Medicine roborant Center.
West MD, Sternberg H, Labat Frenzied, Janus J, Chapman KB, Malik NN, de Grey AD, Larocca D.; Reveal a unified theory of aging scold regeneration.; Regen Med. 2019 Sep;14(9):867-886. doi: 10.2217/rme-2019-0062. Epub 2019 Aug 28.
West Doctor, Chang CF, Larocca D, Li Itemize, Jiang J, Sim P, Labat Side-splitting, Chapman KB, Wong KE, Nicoll Itemize, Van Kanegan MJ, de Grey ADNJ, Nasonkin IO, Stahl A, Sternberg H.; Clonal derivation of white and browned adipocyte progenitor cell lines from soul in person bodily pluripotent stem cells.; Stem Cell Course Ther. 2019 Jan 8;10(1):7. doi: 10.1186/s13287-018-1087-7.
West MD, Labat I, Sternberg H, Larocca D, Nasonkin I, Chapman KB, Singh R, Makarev E, Aliper A, Kazennov A, Alekseenko A, Shuvalov N, Cheskidova E, Alekseev A, Artemov A, Solon E, Mamoshina P, Pryanichnikov N, Larocca J, Copeland K, Izumchenko E, Korzinkin M, Zhavoronkov; Use of deep neuronal network ensembles to identify embryonic-fetal change-over markers: repression of COX7A1 in brute and cancer cells.; rget. 2017 Dec 28;9(8):7796-7811. doi: 10.18632/oncotarget.23748. eCollection 2018 Jan 30.
West Doctor, Chang CF, Larocca D, Li Itemize, Jiang J, Sim P, Labat Side-splitting, Chapman KB, Wong KE, Nicoll Itemize, Van Kanegan MJ, de Grey ADNJ, Nasonkin IO, Stahl A, Sternberg H.; Clonal derivation of white and browned adipocyte progenitor cell lines from soul in person bodily pluripotent stem cells.; Stem Cell Course Ther. 2019 Jan 8;10(1):7. doi: 10.1186/s13287-018-1087-7.
West MD, Labat I, Sternberg H, Larocca D, Nasonkin I, Chapman KB, Singh R, Makarev E, Aliper A, Kazennov A, Alekseenko A, Shuvalov N, Cheskidova E, Alekseev A, Artemov A, Solon E, Mamoshina P, Pryanichnikov N, Larocca J, Copeland K, Izumchenko E, Korzinkin M, Zhavoronkov; Use of deep neuronal network ensembles to identify embryonic-fetal change-over markers: repression of COX7A1 in brute and cancer cells.; rget. 2017 Dec 28;9(8):7796-7811. doi: 10.18632/oncotarget.23748. eCollection 2018 Jan 30.